Clinical Trial Detail

NCT ID NCT01578551
Title A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Metformin

Carboplatin + Paclitaxel

Bevacizumab

Age Groups: adult

No variant requirements are available.